Literature DB >> 27053845

Genetic variation of occult hepatitis B virus infection.

Hui-Lan Zhu1, Xu Li1, Jun Li1, Zhen-Hua Zhang1.   

Abstract

Occult hepatitis B virus infection (OBI), characterized as the persistence of hepatitis B virus (HBV) surface antigen (HBsAg) seronegativity and low viral load in blood or liver, is a special form of HBV infection. OBI may be related mainly to mutations in the HBV genome, although the underlying mechanism of it remains to be clarified. Mutations especially within the immunodominant "α" determinant of S protein are "hot spots" that could contribute to the occurrence of OBI via affecting antigenicity and immunogenicity of HBsAg or replication and secretion of virion. Clinical reports account for a large proportion of previous studies on OBI, while functional analyses, especially those based on full-length HBV genome, are rare.

Entities:  

Keywords:  Hepatitis B surface antigen; Hepatitis B virus; Occult; Variation

Mesh:

Substances:

Year:  2016        PMID: 27053845      PMCID: PMC4814639          DOI: 10.3748/wjg.v22.i13.3531

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  144 in total

1.  Isolation, characterization and biological significance of hepatitis B virus mutants from serum of a patient with immunologically negative HBV infection.

Authors:  M Schories; T Peters; J Rasenack
Journal:  J Hepatol       Date:  2000-11       Impact factor: 25.083

Review 2.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

3.  Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance.

Authors:  C Pichoud; B Seignères; Z Wang; C Trépo; F Zoulim
Journal:  Hepatology       Date:  1999-01       Impact factor: 17.425

4.  Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy.

Authors:  Joseph Torresi; Linda Earnest-Silveira; Georgia Deliyannis; Kristy Edgtton; Hui Zhuang; Stephen A Locarnini; Janet Fyfe; Tina Sozzi; David C Jackson
Journal:  Virology       Date:  2002-02-15       Impact factor: 3.616

5.  A pilot study of serum microRNA signatures as a novel biomarker for occult hepatitis B virus infection.

Authors:  Yuanyuan Chen; Limin Li; Zhenxian Zhou; Nan Wang; Chen-Yu Zhang; Ke Zen
Journal:  Med Microbiol Immunol       Date:  2012-03-06       Impact factor: 3.402

6.  Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection.

Authors:  Henry Lik-Yuen Chan; Steven Woon-Choi Tsang; Nancy Wai-Yee Leung; Chi-Hang Tse; Yui Hui; John Siu-Lun Tam; Francis Ka-Leung Chan; Joseph Jao-Yiu Sung
Journal:  Am J Gastroenterol       Date:  2002-05       Impact factor: 10.864

7.  Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter.

Authors:  Vaishali Chaudhuri; Ruchi Tayal; Baibaswata Nayak; Subrat Kumar Acharya; Subrat Kumar Panda
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 8.  Hepatitis B virus PreS/S gene variants: pathobiology and clinical implications.

Authors:  Teresa Pollicino; Irene Cacciola; Francesca Saffioti; Giovanni Raimondo
Journal:  J Hepatol       Date:  2014-05-05       Impact factor: 25.083

Review 9.  Persistent occult hepatitis B virus infection: experimental findings and clinical implications.

Authors:  Patricia M Mulrooney-Cousins; Tomasz I Michalak
Journal:  World J Gastroenterol       Date:  2007-11-21       Impact factor: 5.742

10.  Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China.

Authors:  Yong Fang; Qing-Long Shang; Jian-Yu Liu; Di Li; Wei-Zhen Xu; Xu Teng; Hong-Wei Zhao; Li-Juan Fu; Feng-Min Zhang; Hong-Xi Gu
Journal:  J Infect       Date:  2009-03-29       Impact factor: 6.072

View more
  25 in total

Review 1.  Occult Hepatitis Infection in Transfusion Medicine: Screening Policy and Assessment of Current Use of Anti-HBc Testing.

Authors:  Antonella Esposito; Chiara Sabia; Carmela Iannone; Giovanni F Nicoletti; Linda Sommese; Claudio Napoli
Journal:  Transfus Med Hemother       Date:  2017-05-05       Impact factor: 3.747

Review 2.  Occult hepatitis B - the result of the host immune response interaction with different genomic expressions of the virus.

Authors:  George Sebastian Gherlan
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

3.  Molecular characterization of hepatitis B virus in blood donors in Botswana.

Authors:  Wonderful T Choga; Motswedi Anderson; Edward Zumbika; Sikhulile Moyo; Tshepiso Mbangiwa; Bonolo B Phinius; Pinkie Melamu; Mukendi K Kayembe; Ishmael Kasvosve; Theresa K Sebunya; Jason T Blackard; Max Essex; Rosemary M Musonda; Simani Gaseitsiwe
Journal:  Virus Genes       Date:  2018-10-31       Impact factor: 2.332

Review 4.  Update on occult hepatitis B virus infection.

Authors:  Manoochehr Makvandi
Journal:  World J Gastroenterol       Date:  2016-10-21       Impact factor: 5.742

5.  Occult hepatitis B virus infection and surgical outcomes in non-B, non-C patients with curative resection for hepatocellular carcinoma.

Authors:  Hiroki Koga; Keita Kai; Shinichi Aishima; Atsushi Kawaguchi; Koutaro Yamaji; Takao Ide; Junji Ueda; Hirokazu Noshiro
Journal:  World J Hepatol       Date:  2017-12-18

6.  Molecular characterization of occult hepatitis B virus infection in patients with end-stage liver disease in Colombia.

Authors:  Julio Cesar Rendon; Fabian Cortes-Mancera; Juan Carlos Restrepo-Gutierrez; Sergio Hoyos; Maria-Cristina Navas
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

7.  Occult Hepatitis B Virus Infection and Associated Genotypes among HBsAg-negative Subjects in Burkina Faso.

Authors:  Birama Diarra; Albert Théophane Yonli; Pegdwendé Abel Sorgho; Tegwindé Rebeca Compaore; Abdoul Karim Ouattara; Wendpagnangdé Arsène Zongo; Issoufou Tao; Lassina Traore; Serge Théophile Soubeiga; Florencia Wendkuuni Djigma; Dorcas Obiri-Yeboah; Bolni-Marius Nagalo; Virginio Pietra; Rokia Sanogo; Jacques Simpore
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-01-01       Impact factor: 2.576

8.  Decreasing prevalence of Hepatitis B and absence of Hepatitis C Virus infection in the Warao indigenous population of Venezuela.

Authors:  Ruth Y Blanco; Carmen L Loureiro; Julian A Villalba; Yoneira F Sulbarán; Mailis Maes; Jacobus H de Waard; Héctor R Rangel; Rossana C Jaspe; Flor H Pujol
Journal:  PLoS One       Date:  2018-05-25       Impact factor: 3.240

9.  Genetic polymorphisms of HLA-DP and isolated anti-HBc are important subsets of occult hepatitis B infection in Indonesian blood donors: a case-control study.

Authors:  Yan Mardian; Yoshihiko Yano; Widya Wasityastuti; Neneng Ratnasari; Yujiao Liang; Wahyu Aristyaning Putri; Teguh Triyono; Yoshitake Hayashi
Journal:  Virol J       Date:  2017-10-23       Impact factor: 4.099

10.  Synergistic impact of mutations in Hepatitis B Virus genome contribute to its occult phenotype in chronic Hepatitis C Virus carriers.

Authors:  Rajiv Kumar Mondal; Mousumi Khatun; Priyanka Banerjee; Alip Ghosh; Sumanta Sarkar; Amal Santra; Kausik Das; Abhijit Chowdhury; Soma Banerjee; Simanti Datta
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.